Cargando…

Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide

Thalidomide (THD) exhibits antitumor effects in several types of cancer. However, the failure of THD to inhibit tumor growth has also been observed in a number of murine models in vivo. The mechanism involved in the therapeutic failure of THD remains unclear. The present study demonstrated that, acc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qin, Yin, Tao, Wang, Guoping, Guo, Fuchun, Ou, Yuhong, Li, Yi, Wang, Yongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647747/ https://www.ncbi.nlm.nih.gov/pubmed/29075340 http://dx.doi.org/10.3892/etm.2017.5028

Ejemplares similares

Thalidomide Reduces Vascular Endothelial Growth Factor Immunostaining in Canine Splenic Hemangiosarcoma
por: Bray, Jonathan P., et al.
Publicado: (2020)

Effect of thalidomide on the expression of vascular endothelial growth factor in a rat model of liver regeneration
por: HUNG, KUO-CHEN, et al.
Publicado: (2013)

Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells
por: Salemi, Mahdieh, et al.
Publicado: (2017)

Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells
por: Kian, Mahnaz Mohammadi, et al.
Publicado: (2018)

Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3
por: Qian, Shenxian, et al.
Publicado: (2005)

The VAD Scheme versus Thalidomide plus VAD for Reduction of Vascular Endothelial Growth Factor in Multiple Myeloma: A Meta-Analysis
por: He, Gan-Lin, et al.
Publicado: (2018)

Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model
por: YIN, TAO, et al.
Publicado: (2015)

Thalidomide—Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses
por: Malik, Sara, et al.
Publicado: (2021)

Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide
por: Chen, Haiying, et al.
Publicado: (2016)

Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain
por: Ma, Kaige, et al.
Publicado: (2023)

Galectin-3 Enhances Vascular Endothelial Growth Factor-A Receptor 2 Activity in the Presence of Vascular Endothelial Growth Factor
por: Cano, Issahy, et al.
Publicado: (2021)

Thalidomide for the Treatment of Refractory Multiple Myeloma: Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
por: Kakimoto, Tsunayuki, et al.
Publicado: (2002)

Rethinking thalidomide.
Publicado: (1995)

Thalidomide and neurotrophism
por: Soper, Judith R., et al.
Publicado: (2018)

Thalidomide for prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation
por: Song, Geng, et al.
Publicado: (2022)

Vascular endothelial growth factor‐C in activating vascular endothelial growth factor receptor‐3 and chemokine receptor‐4 in melanoma adhesion
por: Hlophe, Yvette N., et al.
Publicado: (2022)

A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor
por: Hattori, Y, et al.
Publicado: (2013)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
por: Aldridge, S E, et al.
Publicado: (2005)

Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells
por: Tamilarasan, KP, et al.
Publicado: (2006)

Vascular Endothelial Growth Factor expression in peripheral blood of patients with pregnancy induced hypertension syndrome and its clinical significance
por: Ren, Yanfang, et al.
Publicado: (2014)

Thalidomide in Dermatology: Revisited
por: Hassan, Iffat, et al.
Publicado: (2015)

Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities
por: Bayudan, Alexis Mae, et al.
Publicado: (2020)

Death and Rebirth of the Thalidomide Molecule: A Case of Thalidomide-Induced Sensory Neuropathy
por: Kesserwani, Hassan
Publicado: (2021)

Vascular Endothelial Growth Factor Receptor-1 Expression in Breast Cancer and Its Correlation to Vascular Endothelial Growth Factor A
por: Srabovic, Nahida, et al.
Publicado: (2013)

Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in esophageal squamous cell carcinoma
por: OMOTO, ITARU, et al.
Publicado: (2014)

Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma
por: Zhang, Shiwu, et al.
Publicado: (2008)

Thalidomide—A novel therapeutic approach for pruritic papular eruption of HIV
por: Wernham, Aaron Giles, et al.
Publicado: (2015)

Mechanoregulation of Vascular Endothelial Growth Factor Receptor 2 in Angiogenesis
por: Miller, Bronte, et al.
Publicado: (2022)

Vascular Endothelial Growth Factor Ligands and Receptors in Breast Cancer
por: Brogowska, Klaudia Katarzyna, et al.
Publicado: (2023)

Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
por: He, Jianbo, et al.
Publicado: (2015)

Thalidomide for Patients with β-Thalassemia: A Multicenter Experience
por: Yang, Kun, et al.
Publicado: (2020)

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis
Publicado: (1994)

Thalidomide inhibits inflammation and angiogenesis in tumor 4T1 growth in mice
por: Souza, Cristina M, et al.
Publicado: (2013)

PHARMACEUTICALS: New Insights into Thalidomide
por: Brown, Valerie J.
Publicado: (2009)

Therapy of Angiosarcoma with Thalidomide and Lenalidomide
por: Mattes, M. Jules, et al.
Publicado: (2021)

A history of thalidomide in India
por: Wimmelbücker, Ludger, et al.
Publicado: (2023)

Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye
por: Michael, Iacovos P, et al.
Publicado: (2014)

Correlation of vascular endothelial growth factor and vascular endothelial growth factor receptor-1 levels in serum and thyroid nodules with histopathological and radiological variables
por: Haytaoglu, Gurkan, et al.
Publicado: (2019)

Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
por: Zhang, Ze-Feng, et al.
Publicado: (2014)

Vascular endothelial growth factors and vascular permeability
por: Bates, David O.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9qiqo5nlkfev3omgg5oghm9bbn